Skipping neck radiation for low-risk nasopharyngeal cancer
Part of Cancer, Ear, nose & throat clinical trials.
This trial tests whether it is safe to skip radiation to part of the neck for people with nasopharyngeal carcinoma whose lymph nodes are only in a certain area. The goal is to reduce side effects while still controlling the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with nasopharyngeal carcinoma (a type of cancer in the back of the nose/throat).
- Your cancer has not spread to other parts of the body.
- You are physically able to carry on daily activities (ECOG score 0 or 1).
- Any suspicious lymph nodes in your neck are only at or above the level of the Adam's apple.
- You have no suspicious lymph nodes on the same side of the neck at the very top (level IIb) or middle (level III).
- You have no serious medical conditions like uncontrolled heart disease, diabetes, or active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a simpler way to plan radiation for a type of throat cancer called nasopharyngeal carcinoma. It uses a standard method to outline the area needing treatment, which may make planning faster and more consistent.
This trial tests whether intense radiation therapy (IMRT) alone is effective for people with stage IB nasopharyngeal carcinoma (a type of head and neck cancer) that has not spread to lower lymph nodes or formed large, matted nodes. If you qualify, you would receive targeted radiation without chemotherapy.
This trial tests whether patients with early-stage oral cancer who have surgery and lymph-node removal can skip radiation to the neck if certain favorable conditions are met. The goal is to reduce side effects like difficulty swallowing while keeping cancer control strong.
This study tests if giving a lower dose of radiation to the neck area (where the cancer hasn't spread) is just as safe and effective as the standard dose in people with nasopharyngeal cancer. The goal is to reduce side effects while maintaining cancer control.
This trial tests whether giving radiation only to the specific lymph nodes that need it works as well as standard radiation for people with nasopharyngeal cancer. It aims to reduce side effects while still controlling the cancer.
This trial tests whether a personalized radiation plan for the neck can prevent cancer from spreading in people with nasopharyngeal carcinoma. It's for those whose cancer hasn't spread beyond the head and neck area.
Hear when a new Nasopharyngeal Carcinoma by AJCC V9 Stage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.